{
    "symbol": "AGRX",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-12 20:58:11",
    "content": " Beginning in the third quarter of 2021, we started to see steady demand growth and we believe that three part business plan we introduced on the fourth quarter call of 2021 is contributing to the continued momentum in the early stages of 2022. During the first quarter of 2022, we focused on initiating and mobilizing the Afaxys partnership, and we believe we're beginning to see the positive results into April and May of 2022. For those who are interested in viewing the ad to  target demographics, it is available on Twirla's YouTube channel We continue to execute in our plan for 2022 and focus on building upon the momentum we established through 2021 and now into the first quarter of 2022. Based on the prescription data trends we are now seeing so far in quarter two and the advancement of our Twirla business plan, we currently expect to report a fourth quarter of consecutive growth and strong demand growth for the second quarter of 2022 and provide further proof points that our business plan is now delivering."
}